N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Clinical trial NCT06528496 · RECRUITING

Trial details

NCT number: NCT06528496
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-risk Neuroblastoma Neuroblastoma Childhood Neuroblastoma

Start date: 2024-07-22
Primary completion: 2029-07-22
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.